First case series on the use of calcipotriol-betamethasone dipropionate for morphoea [5]

British Journal of Dermatology

Volumn 157, Issue 3, 2007, Pages 615-618

  Dytoc, M T ^a   Kossintseva, I ^a   Ting, P T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTINUCLEAR ANTIBODY; BETAMETHASONE; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; CALCIPOTRIOL; CENTROMERE ANTIBODY; COLCHICINE; CONNECTIVE TISSUE GROWTH FACTOR; CORTICOSTEROID; GAMMA INTERFERON; IMIQUIMOD; INTERLEUKIN 10; INTERLEUKIN 8; METHOTREXATE; PENICILLAMINE; SALAZOSULFAPYRIDINE; STEROID; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LETTER; MALE; MONOTHERAPY; MORPHOEA; PHOTOTHERAPY; PHYSIOTHERAPY; PRIORITY JOURNAL; SKIN FIBROSIS;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; CALCITRIOL; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, LOCALIZED; TREATMENT OUTCOME;

EID: 34547868505     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07971.x     Document Type: Letter

References (10)

1. Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol 2006 18 : 606 13.
2. Sapadin AN, Fleischmajer R. Treatment of scleroderma. Arch Dermatol 2002 138 : 99 105.
3. Jablonska S, Blaszczyk M. Scleroderma and sclerotic skin conditions: unapproved treatments. Clin Dermatol 2002 20 : 634 7.
4. Dytoc M, Ting PT, Man J et al. First case series on the use of imiquimod for morphoea. Br J Dermatol 2005 153 : 815 20.
5. Cunningham BB, Landells ID, Langman C et al. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol 1998 39 : 211 15.
6. Bottomley WW, Jutley J, Wood EJ et al. The effect of calcipotriol on lesional fibroblasts from patients with active morphoea. Acta Derm Venereol (Stockh) 1995 75 : 364 6.
7. Cosnes A, Anglade MC, Revuz J et al. Thirteen-megahertz ultrasound probe: its role in diagnosing localized scleroderma. Br J Dermatol 2003 148 : 724 9.
8. Ihn H. Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol 2002 14 : 681 5.
9. Wagner TL, Ahonen CL, Couture AM et al. Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod. Cell Immunol 1999 191 : 10 19.
10. Kang S, Yi S, Griffiths CEM et al. Calcipotriene-induced improvement in psoriasis is associated with reduced interleukin-8 and increased interleukin-10 levels within lesions. Br J Dermatol 1998 138 : 77 83.